Related Experiment Videos
ADAM23 methylation and expression analysis in brain tumors
Fabrício F Costa1, Christian Colin, Sueli M O Shinjo
1Laboratory of Molecular Biology and Genomics, Ludwig Institute for Cancer Research, SP, Brazil.
Neuroscience Letters
|May 3, 2005
Summary
Methylation of the ADAM23 gene is higher in certain brain tumor cells but rarely causes down-regulation in actual brain tumors. This finding may explain the low rate of brain tumor metastasis.
Area of Science:
- Molecular Biology
- Oncology
- Neuroscience
Background:
- ADAMs are cell surface proteins involved in cell interactions and protease activity.
- ADAM23, an adhesion molecule, plays a role in cellular functions.
- Understanding gene regulation in brain tumors is crucial for therapeutic development.
Purpose of the Study:
- To investigate the expression and methylation status of the ADAM23 gene in brain tumors.
- To determine the correlation between ADAM23 methylation and its expression in brain tumor cell lines and primary tumors.
- To explore the potential role of ADAM23 down-regulation in brain tumor metastasis.
Main Methods:
- Bisulfite sequencing was used to analyze the methylation status of the 5' upstream region of ADAM23.
- Quantitative analysis of ADAM23 mRNA and protein expression levels was performed.
- Expression and methylation were examined in two brain tumor cell lines (A172, T98G), primary brain tumors, and glioblastoma xenografts.
Main Results:
- A higher percentage of methylated dinucleotides was observed in T98G cells compared to A172 cells.
- Methylation of ADAM23 significantly correlated with its mRNA and protein expression in cell lines.
- No significant methylation or down-regulation of ADAM23 was detected in the analyzed primary brain tumors and xenografts.
Conclusions:
- Down-regulation of ADAM23 by methylation is an infrequent event in brain tumors.
- The study suggests that epigenetic silencing of ADAM23 is not a primary mechanism driving its reduced expression in brain tumors.
- The findings may offer insights into the limited metastatic potential of brain tumors.